Product showcase
A partner for medical-grade custom glass manufacturing
MO-SCI specialises in manufacturing technical glass materials, such as glass powders, microspheres and ingots specifically designed and manufactured for the medical industry.
Materials in the market
MO-SCI materials, like bioactive glass and precision glass microspheres, can be found in numerous medical devices on the market today. The company has melting capabilities for temperatures up to 1,600°C and quantities from a few kilograms up to several thousand kilograms annually.
Unique capabilities
Its unique in-house capabilities allow it to melt larger quantities in a variety of crucible types. Customers look to MO-SCI when they need high-purity implant or medical-grade glass materials, or custom glass compositions specific to their application needs. Other service capabilities offered include glass analytics, coatings, spheroidisation and glass development. MO-SCI also serves the aerospace, energy, automotive and defence industries, among others. MO-SCI is ISO 9001 and AS9100-certified. ●
MO-SCI produces technical glass materials for medical devices. MO-SCI /
www.mo-sci.com Gelatine for targeted performance
In medical device development, performance, purity and regulatory readiness are essential. The X-Pure®
gelatine range of premium products is designed with ultra-low endotoxin levels (≤10 EU/g), over 100 times lower than traditional gelatine. Customisable and reliable, X-Pure gelatine supports FDA medical device submissions and EU MDR (2017/745) requirements, helping medical manufacturers accelerate product development.
Safe haemostasis
X-Pure is designed for use in, among others, haemostatic sponges, anti-adhesion films and flowable haemostats, offering targeted performance and excellent handling properties for development. With customisable bloom strength, viscosity and molecular weight, X-Pure can be used to create foaming or expanding structures that mould to the wound shape and enhance clotting, while supporting biocompatibility and safe biodegradation.
Targeted embolisation With its customisable properties such as degradation profile, sterility
Microneedle patch: a delicate, minimally invasive method of application.
and proven biocompatibility, X-Pure gelatine is an ideal biomaterial for use in embolisation products. It can be easily moulded into different forms, including microspheres and foams, enabling physicians to target specific vessels or tissues more accurately. Embolisation devices must meet rigorous compliance requirements. X-Pure offers full traceability, readily available documentation, and validated viral inactivation, helping to streamline clinical transitions.
Precision drug delivery via microneedles
Using microneedles, with their delicate, minimally invasive method of application, for drug delivery demands biomaterials with high purity and
mechanical precision. With its batch-to-batch consistency and tuneable properties, X-Pure ensures uniform patch fabrication, controlled release and scalable production. X-Pure bridges innovation and regulation, offering medical device developers a high-purity, customisable material that upholds high safety standards while streamlining the regulatory journey under the EU MDR and offering documentation to support ISO 22442 compliance of your device. ●
Rousselot /
www.darlingii.com/en/rousselot/contact-biomedical 124
www.medicaldevice-developments.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130
